Related Experiment Video
Updated: May 9, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Induced abortions in women with rheumatoid arthritis receiving methotrexate
Évelyne Vinet1, Bindee Kuriya, Christian A Pineau
1McGill University Health Centre, Montreal, Quebec, Canada. evelyne.vinet@mail.mcgill.ca
Objective:
To determine the rate of induced abortions in women with rheumatoid arthritis (RA) exposed to methotrexate (MTX) compared with women with RA unexposed to this medication.
Methods:
We performed a nested case-control study using administrative databases from Quebec. All women with RA ages 15-45 years were identified and cases were defined as women having an induced abortion. Each case was matched to ≥1 controls for age, calendar time, and cohort entry. Exposure was defined as having filled ≥1 prescriptions of MTX ≤16 weeks prior to the index date.
Results:
We identified 112 cases of induced abortions in women with RA and 5,855 RA controls. Exposure to MTX occurred in 10.7% of cases and 21.7% of controls. Women exposed to MTX had a lower rate of induced abortions compared with unexposed women (rate ratio [RR] 0.47 [95% confidence interval (95% CI) 0.25-0.89]). In the multivariate analysis, there was a trend toward an increased rate of induced abortions among women exposed to anti-tumor necrosis factor (anti-TNF) agents (RR 2.07 [95% CI 0.81-5.27]).
Conclusion:
Women with RA exposed to MTX have a lower rate of induced abortions than unexposed women. Women with RA exposed to anti-TNF agents may have an increased rate of induced abortions compared to unexposed women.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Therapeutic Drug Monitoring: Affecting Factors
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management